CHRISTY DUNBAR: Open Payments
NPI 1366437907 · LEESVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$617 in 34 payments from 10 companies in 2025. Trend: 2023 $1,281 · 2024 $986 · 2025 $617
Food & beverage: $617
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $194 |
| Forte Bio-Pharma LLC | 8 | $137 |
| Novo Nordisk Inc | 4 | $63 |
| Exact Sciences Corporation | 3 | $54 |
| PFIZER INC. | 2 | $35 |
| ABBVIE INC. | 2 | $31 |
| GlaxoSmithKline, LLC. | 2 | $31 |
| HARMONY BIOSCIENCES LLC | 1 | $29 |
| Optinose US, Inc. | 1 | $23 |
| Stryker Corporation | 1 | $19 |
Products named: PROLATE, FARXIGA, Ozempic, Cologuard Collection Kit, BREZTRI, NURTEC ODT, VRAYLAR, TRELEGY ELLIPTA.
Industry payments across SC — which companies pay providers there.
